309258
Reasons for CRC screening non-adherence among African Americans in primary care
Methods: 764 participants were randomized either to a Tailored Navigation Intervention (TNI) Group (n=384) or a Standard Intervention (SI) Group (n=380). An endpoint telephone survey was administered to 519 (68%) participants. Respondents who had not screened at 6 months were asked to report a primary reason for non-adherence.
Results: 388 endpoint survey respondents indicated that that they had not completed a screening test. Of this number, 243 (63%) reported a primary reason for why they did not screen. Primary reasons for non-adherence were distributed as follows: low perceived importance of CRC screening (28%), lack of transportation or time needed to attend a screening appointment (17%), fear of screening or results (11%), dislike of screening procedures (11%), lack of insurance coverage or limited capacity to pay for screening and follow-up (10%), confusion about the screening process (10%), existence of a health condition that precluded screening (8%), and other reasons (5%).
Conclusions: CRC screening non-adherence among AAs was influenced by negative perceptions and confusion related to screening, lack of access to testing, concerns about cost, and health limitations. Initiatives seeking to maximize screening rates among AAs should be designed to identify and address both perceptual and logistical barriers to screening.
Learning Areas:
Diversity and culturePlanning of health education strategies, interventions, and programs
Social and behavioral sciences
Learning Objectives:
Identify barriers to CRC screening among African Americans.
Discuss relative importance of identified barriers to CRC screening.
Explore approaches that may be used to address barriers to screening that can be ameliorated.
Keyword(s): Cancer Prevention and Screening, Minority Health
Qualified on the content I am responsible for because: I have been the project manager on federally funded grants focusing on CRC Screening. On this particular project I have been involved in development, implementation, analyses and publication development.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.